Roche, Eli Lilly gain FDA breakthrough device tag for Alzheimer's blood test [Seeking Alpha]
Lindsay Corporation (LNN)
Last lindsay corporation earnings: 4/7 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
lindsayir.com
Company Research
Source: Seeking Alpha
Food and Drug Administration (FDA) for their Elecsys pTau217 assay to support early diagnosis of Alzheimer's disease. The Elecsys pTau217 plasma biomarker test is being developed as part of an ongoing partnership between Roche( OTCQX:RHHBY ) and Eli Lilly ( LLY ). The test is intended to be an in-vitro diagnostic immunoassay for use as an aid in identifying amyloid pathology, a pathological feature of Alzheimer's disease. pTau217, which is a phosphorylated fragment of the protein tau, is a biomarker that has shown the ability in research settings to distinguish Alzheimer's disease from other neurodegenerative disorders and has shown strong performance relative to other biomarkers. Roche ( OTCQX:RHHBY entered a collaboration with Eli Lilly ( LLY ) in March last year to support development of Roche's Elecsys Amyloid Plasma Panel to facilitate the earlier diagnosis of Alzheimer's disease. Recommended For You More Trending News Recommended For You More Trending News Relate
Show less
Read more
Impact Snapshot
Event Time:
LNN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LNN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LNN alerts
High impacting Lindsay Corporation news events
Weekly update
A roundup of the hottest topics
LNN
News
- Lindsay Co. (NYSE: LNN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Why Roche Holdings Stock Popped Today [Yahoo! Finance]Yahoo! Finance
- Roche, Eli Lilly Alzheimer's Blood Test to Get Expedited FDA Review [MarketWatch]MarketWatch
- Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis [Yahoo! Finance]Yahoo! Finance
- Micro Irrigation and Mechanized Systems Market To Reach USD 50.5 Billion By 2032 - DataHorizzon Research [Yahoo! Finance]Yahoo! Finance
LNN
Earnings
- 4/4/24 - Beat
LNN
Sec Filings
- 4/4/24 - Form 10-Q
- 4/4/24 - Form 8-K
- 2/13/24 - Form SC
- LNN's page on the SEC website